{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:14:41Z","timestamp":1773310481677,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":402,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CS\/15\/1\/31175"],"award-info":[{"award-number":["CS\/15\/1\/31175"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CS\/15\/1\/31175"],"award-info":[{"award-number":["CS\/15\/1\/31175"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Concerns exist that intravenous (IV) iron might increase the risk of infections. The IRONMAN trial provided an opportunity to investigate whether giving IV ferric derisomaltose (FDI) to patients with heart failure and iron deficiency alters the rate of hospitalization or death due to infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>IRONMAN was a randomized trial of IV FDI versus usual care in patients with symptomatic heart failure, left ventricular ejection fraction (LVEF) \u226445%, and transferrin saturation (TSAT) &amp;lt;20% or ferritin &amp;lt;100\u2009\u03bcg\/L. Infection was a pre-specified, blindly-adjudicated, safety endpoint. The primary analysis of interest was infection as the main reason for hospitalization or death, using first and recurrent events analyses. The composite primary event of interest tended to be lower in those randomized to FDI when analysed as first (hazard ratio [HR] 0.79, 95% confidence interval [CI] 0.62\u20131.01, p\u2009=\u20090.055) or recurrent event (rate ratio 0.85, 95% CI 0.64\u20131.13, p\u2009=\u20090.089). The composite results were driven by fewer hospitalizations for infection (HR 0.76, 95% CI 0.49\u20130.98, p\u2009=\u20090.032), with 5% fewer patients (absolute reduction) experiencing such an event if assigned to FDI. Similar trends were observed for recurrent events (HR 0.82, 95% CI 0.62\u20131.10). Further analyses suggested that the reduction in hospitalizations due to infection with FDI was restricted to patients with TSAT &amp;lt;20%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with heart failure and a reduced LVEF, correction of iron deficiency is not associated with an increased risk of hospitalization or death from infection, and may reduce such events, especially when TSAT is &amp;lt;20%.<\/jats:p>\n                    <jats:p>Clinical Trial Registration: ClinicalTrials.gov, NCT02642562.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3504","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:04:33Z","timestamp":1729857873000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of Correcting Iron Deficiency on the Risk of Serious Infection in Heart Failure: Insights from the IRONMAN Trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4856-832X","authenticated-orcid":false,"given":"Paul W.","family":"Foley","sequence":"first","affiliation":[{"name":"The Great Western Hospital , Swindon ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Kalra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Portsmouth Hospitals University NHS Trust , Portsmouth ,","place":["UK"]},{"name":"College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Faculty of Science and Health, University of Portsmouth , Portsmouth ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Petrie","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust , Salford ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Squire","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Glenfield Hospital , Leicester ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Campbell","sequence":"additional","affiliation":[{"name":"Royal Gwent Hospital , Newport ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callum","family":"Chapman","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Ulster Hospital Southeastern Health and Social Care Trust , Belfast ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Graham","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hannah","sequence":"additional","affiliation":[{"name":"Aberdeen Royal Infirmary , Aberdeen ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninian N.","family":"Lang","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Matthews","sequence":"additional","affiliation":[{"name":"Wansbeck General Hospital , Ashington ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Leslie","sequence":"additional","affiliation":[{"name":"Cardiac Unit, Raigmore Hospital , Inverness ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Piper","sequence":"additional","affiliation":[{"name":"Kings College Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Ray","sequence":"additional","affiliation":[{"name":"St Georges Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernry O.","family":"Savage","sequence":"additional","affiliation":[{"name":"Mid and South Essex NHS Foundation Trust , Basildon ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chales","family":"Spencer","sequence":"additional","affiliation":[{"name":"New Cross Hospital , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Walsh","sequence":"additional","affiliation":[{"name":"Nottingham University Hospital, Nottingham City Hospital , Nottingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk-Ki","family":"Wong","sequence":"additional","affiliation":[{"name":"St Richard's Hospital , Chichester ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the IRONMAN Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"2026010913032326500_ejhf3504-bib-0001","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026010913032326500_ejhf3504-bib-0002","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026010913032326500_ejhf3504-bib-0003","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"2026010913032326500_ejhf3504-bib-0004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2017-03-772715","article-title":"Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron","volume":"130","author":"Stefanova","year":"2017","journal-title":"Blood"},{"key":"2026010913032326500_ejhf3504-bib-0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000339285","article-title":"Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes","volume":"36","author":"Ichii","year":"2012","journal-title":"Am J Nephrol"},{"key":"2026010913032326500_ejhf3504-bib-0006","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.medj.2020.10.004","article-title":"Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection","volume":"2","author":"Frost","year":"2021","journal-title":"Med"},{"key":"2026010913032326500_ejhf3504-bib-0007","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026010913032326500_ejhf3504-bib-0008","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ndt\/gfu349","article-title":"Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: A comparative effectiveness analysis from the DEcIDE-ESRD study","volume":"30","author":"Tangri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026010913032326500_ejhf3504-bib-0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33935","article-title":"Risk of infection associated with administration of intravenous iron: A systematic review and meta-analysis","volume":"4","author":"Shah","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026010913032326500_ejhf3504-bib-0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bjh.17202","article-title":"Intravenous iron: Do we adequately understand the short- and long-term risks in clinical practice?","volume":"193","author":"Rund","year":"2021","journal-title":"Br J Haematol"},{"key":"2026010913032326500_ejhf3504-bib-0011","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N Engl J Med."},{"key":"2026010913032326500_ejhf3504-bib-0012","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ejhf.3209","article-title":"Heart failure and respiratory tract infection: Cause and consequence of acute decompensation?","volume":"26","author":"Heidecker","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026010913032326500_ejhf3504-bib-0013","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1136\/heartjnl-2022-321304","article-title":"Rationale and design of a randomised trial of intravenous iron in patients with heart failure","volume":"108","author":"Kalra","year":"2022","journal-title":"Heart"},{"key":"2026010913032326500_ejhf3504-bib-0014","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: The IRONMAN trial","volume":"45","author":"Cleland","year":"2024","journal-title":"Eur Heart J"},{"key":"2026010913032326500_ejhf3504-bib-0015","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events","volume":"62","author":"Lin","year":"2000","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026010913032326500_ejhf3504-bib-0016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.0006-341X.2000.00554.x","article-title":"Nonparametric analysis of recurrent events and death","volume":"56","author":"Ghosh","year":"2000","journal-title":"Biometrics"},{"key":"2026010913032326500_ejhf3504-bib-0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MNH.0000000000000263","article-title":"Safety of intravenous iron use in chronic kidney disease","volume":"25","author":"Kalra","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2026010913032326500_ejhf3504-bib-0018","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3324\/haematol.2020.250803","article-title":"Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways","volume":"106","author":"Garbowski","year":"2020","journal-title":"Haematologica"},{"key":"2026010913032326500_ejhf3504-bib-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41569-023-00951-6","article-title":"Defining iron deficiency in patients with heart failure","volume":"21","author":"Cleland","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026010913032326500_ejhf3504-bib-0020","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: An individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"key":"2026010913032326500_ejhf3504-bib-0021","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bmj.280.6226.1249","article-title":"Humoral immune response in children with iron-deficiency anaemia","volume":"280","author":"Bagchi","year":"1980","journal-title":"Br Med J"},{"key":"2026010913032326500_ejhf3504-bib-0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.3.5982.522","article-title":"Cell mediated immunity in iron- and vitamin-deficient children","volume":"3","author":"Bhaskaram","year":"1975","journal-title":"Br Med J"},{"key":"2026010913032326500_ejhf3504-bib-0023","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltab007","article-title":"Adaptive immunity and vaccination \u2013 Iron in the spotlight","volume":"1","author":"Preston","year":"2021","journal-title":"Immunother Adv"},{"key":"2026010913032326500_ejhf3504-bib-0024","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jacc.2021.03.001","article-title":"Incidence and outcomes of pneumonia in patients with heart failure","volume":"77","author":"Shen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026010913032326500_ejhf3504-bib-0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ejhf.3180","article-title":"Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026010913032326500_ejhf3504-bib-0026","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3026(21)00201-5","article-title":"Vaccine efficacy and iron deficiency: An intertwined pair?","volume":"8","author":"Drakesmith","year":"2021","journal-title":"Lancet Haematol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/1\/166\/65346863\/eurjhf_27_1_166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/1\/166\/65346863\/eurjhf_27_1_166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:03:49Z","timestamp":1767981829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/1\/166\/8322624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,25]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3504","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"2024-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}